PARP Inhibitor Maintenance in Newly Diagnosed Ovarian Cancer: Key Questions, Answers, and Insights 

Join the faculty for a discussion on emerging clinical data and guidance on the use of PARP inhibitors for managing newly diagnosed OC. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/948129?src=mkm_podcast_addon_948129